World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
46
Citations
9256
World Ranking
2802
National Ranking
70

Overview

Sue Fletcher is affiliated with Murdoch University in Australia and has contributed extensively to the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their research spans multiple subfields including Molecular Biology, Genetics, Neurology, Ophthalmology, and Cellular and Molecular Neuroscience.

The main topics of their work encompass:

  • Retinal Development and Disorders
  • RNA Interference and Gene Delivery
  • RNA Research and Splicing
  • Neurogenetic and Muscular Disorders Research
  • Advanced biosensing and bioanalysis techniques
  • Retinal Diseases and Treatments
  • RNA and protein synthesis mechanisms

Among the recent papers that highlight key contributions are:

  • "NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastoma," 2020, published in Cellular and Molecular Life Sciences
  • "Structural Variants May Be a Source of Missing Heritability in sALS," 2020, published in Frontiers in Neuroscience
  • "Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era," 2020, published in Medicinal Research Reviews
  • "Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype," 2021, published in Frontiers in Aging Neuroscience
  • "Stargardt disease and progress in therapeutic strategies," 2021, published in Ophthalmic Genetics

The venues where Fletcher frequently publishes include:

  • International Journal of Molecular Sciences
  • Frontiers in Genetics
  • Stem Cell Research
  • Ophthalmic Genetics
  • Genes

Frequent co-authors in Fletcher's work include:

  • Steve D. Wilton
  • May T. Aung-Htut
  • Samuel McLenachan
  • Fred K. Chen
  • Dan Zhang

Best Publications

  • Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements

    Lucy W. Barrett;Sue Fletcher;Steve D. Wilton

  • ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

    Rita Mejzini;Loren Louise Flynn;Loren Louise Flynn;Ianthe Leigh Pitout;Ianthe Leigh Pitout;Sue Fletcher;Sue Fletcher

  • Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.

    Qi Long Lu;Christopher J Mann;Fang Lou;George Bou-Gharios

  • Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse

    Christopher J. Mann;Kaite Honeyman;Andy J. Cheng;Tina Ly

  • Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript.

    Steve D Wilton;Abbie M Fall;Penny L Harding;Graham McClorey

  • Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides

    Stephen D Wilton;Frances Lloyd;Kylie Carville;Sue Fletcher

  • Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD

    Graham Mcclorey;H.M. Moulton;P.L. Iversen;Susan Fletcher

  • Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle

    Bianca L. Gebski;Chrisopher J. Mann;Susan Fletcher;Stephen D. Wilton

  • Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide

    Susan Fletcher;Kaite Honeyman;Abbie M. Fall;Penny L. Harding

  • Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy.

    Christopher J. Mann;Kaite Honeyman;Graham McClorey;Sue Fletcher

  • Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse.

    Sue Fletcher;Kaite Honeyman;Abbie M Fall;Penny L Harding

  • Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.

    Aurélie Goyenvalle;Arran Babbs;Dave Powell;Ryszard Kole

  • The influence of antisense oligonucleotide length on dystrophin exon skipping.

    Penny Harding;Abbie Fall;K. Honeyman;Susan Fletcher

  • Induced dystrophin exon skipping in human muscle explants

    Graham Mcclorey;Abbie Fall;H.M. Moulton;P.L. Iversen

  • Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene

    Stephen J. Errington;Christopher J. Mann;Sue Fletcher;Stephen D. Wilton

  • Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.

    H M Moulton;S Fletcher;B W Neuman;G McClorey

  • Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm

    Philip Doran;Steve D. Wilton;Sue Fletcher;Kay Ohlendieck

  • High-Level Dystrophin Expression after Adenovirus-Mediated Dystrophin Minigene Transfer to Skeletal Muscle of Dystrophic Dogs: Prolongation of Expression with Immunosuppression

    John McC. Howell;Hanns Lochmüller;Amanda O'Hara;Susan Fletcher

  • Rational Design of Antisense Oligomers to Induce Dystrophin Exon Skipping

    Chalermchai Mitrpant;Abbie M Adams;Penny L Meloni;Francesco Muntoni

  • Use of the dog model for Duchenne muscular dystrophy in gene therapy trials

    J.Mcc. Howell;Susan Fletcher;Byron Kakulas;M. O'Hara

Frequent Co-Authors

Steve D. Wilton
Steve D. Wilton University of Western Australia
Patrick L. Iversen
Patrick L. Iversen Oregon State University
Francesco Muntoni
Francesco Muntoni University College London
Frank L. Mastaglia
Frank L. Mastaglia University of Western Australia
Arthur H.M. Burghes
Arthur H.M. Burghes The Ohio State University
John E.J. Rasko
John E.J. Rasko Centenary Institute of Cancer Medicine and Cell Biology
Alan H. Bittles
Alan H. Bittles Edith Cowan University
John Papadimitriou
John Papadimitriou University of Western Australia
Nigel G. Laing
Nigel G. Laing University of Western Australia
David A. Mackey
David A. Mackey University of Western Australia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology opens doors to diverse online degrees and career options in healthcare and research. For those already in nursing, flexible education paths like a 6 month rn to bsn program allow registered nurses to quickly advance their credentials. Such programs often appeal to professionals eager to enhance their skills and improve patient outcomes without disrupting their careers.

If you’re looking to progress further, bridge programs such as the adn to fnp track support career moves from an associate’s degree directly into advanced practice nursing roles. For those without a nursing background interested in the clinical side of molecular sciences, online msn programs for non nurses provide a streamlined entry path into the profession.

When considering online study, selecting the right institution can make all the difference. Review resources comparing the top rated online nursing schools wgu and others, focusing on accreditation, program length, and student support. Whether you’re pursuing research or clinical practice, these flexible online options can help expand your expertise in molecular biology and related health sciences.

Best Scientists Citing Sue Fletcher

Trending Scientists

Recently Published Articles